Erector Spinae Plane Block Versus Transcutaneous Radiofrequency in Postherpetic Neuralgia
Which Is More Effective in the Treatment of Postherpetic Neuralgia: Erector Spinae Plane Block or Transcutaneous Radiofrequency?
Diskapi Teaching and Research Hospital
50 participants
Jun 1, 2025
OBSERVATIONAL
Conditions
Summary
This observational study aims to compare the effectiveness of ultrasound-guided erector spinae plane (ESP) block and transcutaneous radiofrequency (RF) treatment in patients with postherpetic neuralgia. Pain intensity and neuropathic pain characteristics will be evaluated using the Visual Analog Scale (VAS) and the Self-Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) score.
Eligibility
Inclusion Criteria4
- Diagnosis of postherpetic neuralgia involving cervical, thoracic, or lumbar regions
- Age between 18 and 80 years
- Persistent pain despite conservative treatment
- Baseline VAS score \> 5
Exclusion Criteria5
- Ophthalmic or extremity postherpetic neuralgia
- Allergy to local anesthetics
- Pregnancy
- Coagulopathy or use of antiplatelet therapy
- Cognitive impairment preventing informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
1. Ultrasound-guided erector spinae plane block performed under sterile conditions as part of routine clinical care. After skin antisepsis, a 22-G spinal needle was advanced to the erector spinae plane at the level corresponding to the affected dermatome, and a total volume of 10 mL consisting of dexamethasone, bupivacaine, and normal saline was injected. Patients were observed post-procedure according to standard clinical practice. 2. Transcutaneous radiofrequency treatment applied adjacent to the affected dermatome as part of routine clinical care. Adhesive surface electrodes were placed over the painful area, and pulsed electrical stimulation was delivered by the device for 10 minutes per session. The procedure was performed once weekly for two sessions, without any modification for research purposes.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07400640